Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system

BackgroundDespite the likely association between coronavirus 2019 (COVID-19) mRNA vaccines and cases of myocarditis/pericarditis, the benefit–risk assessment by the Centers for Disease Control (CDC) still showed a favorable balance for the primary series of COVID-19 mRNA vaccinations. Since August 2...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Congqin Chen, Fang Fu, Lingqing Ding, Jie Fang, Jie Xiao
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-09-01
Serie:	Frontiers in Immunology
Soggetti:	myocarditis pericarditis COVID-19 mRNA vaccination booster dose primary series
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.938322/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!